{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:22:34Z","timestamp":1787440954782,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-KIFZMSX0004"],"award-info":[{"award-number":["CSTB2024NSCQ-KIFZMSX0004"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119588","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T10:39:42Z","timestamp":1780137582000},"page":"119588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MIP-8, a Morchella importuna-derived peptide, protects against 6-OHDA-induced neurotoxicity via AKT signaling modulation"],"prefix":"10.1016","volume":"200","author":[{"given":"Chuan","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1373-1374","authenticated-orcid":false,"given":"Chia-wei","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dachuan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119588_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021","volume":"388","author":"Su","year":"2025","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.biopha.2026.119588_bib2","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/med.22091","article-title":"\u03b1-Synuclein in Parkinson's disease: From bench to bedside","volume":"45","author":"Bellini","year":"2025","journal-title":"Med. Res. Rev."},{"issue":"10291","key":"10.1016\/j.biopha.2026.119588_bib3","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2026.119588_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"20","key":"10.1016\/j.biopha.2026.119588_bib5","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1212\/WNL.0000000000012868","article-title":"Dopaminergic therapy for motor symptoms in early Parkinson disease practice guideline summary: a report of the AAN Guideline Subcommittee","volume":"97","author":"Pringsheim","year":"2021","journal-title":"Neurology"},{"issue":"10423","key":"10.1016\/j.biopha.2026.119588_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","article-title":"Medical, surgical, and physical treatments for Parkinson's disease","volume":"403","author":"Foltynie","year":"2024","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.biopha.2026.119588_bib7","first-page":"899","article-title":"Parkinson's disease drug therapies in the clinical trial pipeline: 2024 update","volume":"14","author":"McFarthing","year":"2024","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.biopha.2026.119588_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105799","article-title":"Unveiling nature's potential: promising natural compounds in Parkinson's disease management","volume":"115","author":"Bhusal","year":"2023","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.biopha.2026.119588_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: Structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.biopha.2026.119588_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jlcr.4023","article-title":"Peptides for trans-blood-brain barrier delivery","volume":"66","author":"Blades","year":"2023","journal-title":"J. Label. Comp. Radio."},{"issue":"11","key":"10.1016\/j.biopha.2026.119588_bib11","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1021\/acs.molpharmaceut.2c00523","article-title":"Peptides as pharmacological carriers to the brain: Promises, shortcomings and challenges","volume":"19","author":"Parrasia","year":"2022","journal-title":"Mol. Pharm."},{"issue":"15","key":"10.1016\/j.biopha.2026.119588_bib12","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.3390\/foods12152935","article-title":"Bioactive peptides from edible mushrooms - The preparation, mechanisms, structure-activity relationships and prospects","volume":"12","author":"Li","year":"2023","journal-title":"Foods"},{"issue":"12","key":"10.1016\/j.biopha.2026.119588_bib13","doi-asserted-by":"crossref","first-page":"12331","DOI":"10.1021\/acs.jmedchem.4c03115","article-title":"Target engagement assays in early drug discovery","volume":"68","author":"St John-Campbell","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119588_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2020.109230","article-title":"A review on mushroom-derived bioactive peptides: Preparation and biological activities","volume":"134","author":"Zhou","year":"2020","journal-title":"Food Res. Int."},{"issue":"5","key":"10.1016\/j.biopha.2026.119588_bib15","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/fsn3.3050","article-title":"Neuroprotective effects of a novel peptide from Lignosus rhinocerotis against 6-hydroxydopamine-induced apoptosis in PC12 cells by inhibiting NF-kappaB activation","volume":"11","author":"Xiong","year":"2023","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.biopha.2026.119588_bib16","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1038\/s41598-025-34188-9","article-title":"RSM and ANN-GA assisted optimization of Morchella importuna extracts and their effects on antioxidant anticholinesterase and antiproliferative activity","volume":"16","author":"Akata","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119588_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2024.1419108","article-title":"Parkinson's disease models and death signaling: What do we know until now?","volume":"18","author":"Pedrao","year":"2024","journal-title":"Front. Neuroanat."},{"issue":"6","key":"10.1016\/j.biopha.2026.119588_bib18","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.3390\/ijms23063009","article-title":"Evaluation of 6-hydroxydopamine and rotenone in vitro neurotoxicity on differentiated SH-SY5Y cells using applied computational statistics","volume":"23","author":"Simoes","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119588_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5563367","article-title":"Induction of apoptosis in HeLa cells by a novel peptide from fruiting bodies of Morchella importuna via the mitochondrial apoptotic pathway","volume":"2021","author":"Xiong","year":"2021","journal-title":"Evid. Based Complement. Altern. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119588_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101993","article-title":"Differentiating PC12 cells to evaluate neurite densities through live-cell imaging","volume":"4","author":"Karliner","year":"2023","journal-title":"STAR Protoc."},{"issue":"17","key":"10.1016\/j.biopha.2026.119588_bib21","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2545","article-title":"Detection of reactive oxygen species (ROS) in cyanobacteria using the oxidant-sensing probe 2\u2032,7\u2032-dichlorodihydrofluorescein diacetate (DCFH-DA)","volume":"7","author":"Rajneesh","year":"2017","journal-title":"Bio Protoc."},{"issue":"2","key":"10.1016\/j.biopha.2026.119588_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","article-title":"A biological classification of Parkinson's disease: The SynNeurGe research diagnostic criteria","volume":"23","author":"Hoglinger","year":"2024","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119588_bib23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","article-title":"A biological definition of neuronal alpha-synuclein disease: Towards an integrated staging system for research","volume":"23","author":"Simuni","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2026.119588_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1664269","article-title":"Parkinson's disease physiopathology - beyond the alpha-synuclein aggregation: A narrative review","volume":"17","author":"Macedo","year":"2025","journal-title":"Front. Aging Neurosci."},{"issue":"10","key":"10.1016\/j.biopha.2026.119588_bib25","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1016\/j.apsb.2023.07.010","article-title":"Oxidative stress, the blood-brain barrier and neurodegenerative diseases: The critical beneficial role of dietary antioxidants","volume":"13","author":"Feng","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biopha.2026.119588_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","article-title":"Signaling pathways in Parkinson's disease: Molecular mechanisms and therapeutic interventions","volume":"8","author":"Dong-Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2026.119588_bib27","doi-asserted-by":"crossref","DOI":"10.26599\/NR.2025.94907916","article-title":"Peptide-based brain distribution improvement strategies for nano delivery systems in CNS diseases treatment","volume":"18","author":"Qian","year":"2025","journal-title":"Nano Res"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:48:46Z","timestamp":1787438926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226006244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":27,"alternative-id":["S0753332226006244"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119588","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MIP-8, a Morchella importuna-derived peptide, protects against 6-OHDA-induced neurotoxicity via AKT signaling modulation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119588"}}